Back to top

RxSight Tarsus CEO Ron Kurtz to depart role, Aziz Mottiwala to succeed

RxSight (RXST) announced a planned leadership transition effective July 20, with Aziz Mottiwala appointed president and CEO, succeeding Ron Kurtz, ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

RxSight, Inc. (RXST)

Tarsus Pharmaceuticals, Inc. (TARS)